Report error Found 59 of ic50 data for polymerid = 11211
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.60E+3nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.00E+3nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.60E+3nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.50E+3nMpH: 5.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 5More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.50E+3nMpH: 5.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 5More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.50E+3nMpH: 5.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 5More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.10E+3nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.10E+3nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PTPalpha (unknown origin)More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PTPalpha (unknown origin) expressed in Escherichia coli using pNPP substrate after 5 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PTPalpha (unknown origin) expressed in Escherichia coli using pNPP substrate after 5 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PTPalpha (unknown origin) expressed in Escherichia coli using pNPP substrate after 5 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.30E+4nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.30E+4nMAssay Description:The compound was tested in vitro for the inhibitory activity against Protein-tyrosine phosphatase 1 alpha (LRP) (human PTPases.)More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:In vitro inhibitory concentration required against Protein-tyrosine phosphatase alpha in the presence of 300 nM DTTMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.70E+4nMAssay Description:The compound was tested in vitro for the inhibitory activity against Protein-tyrosine phosphatase 1 alpha (LRP) (human PTPases.)More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.40E+4nMAssay Description:In vitro inhibitory concentration required against Protein-tyrosine phosphatase alpha in the presence of 300 nM DTTMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.80E+4nMAssay Description:In vitro inhibitory concentration required against Protein-tyrosine phosphatase alpha in the presence of 300 nM DTTMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.37E+4nMAssay Description:Inhibition of PTPalpha (unknown origin)More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human recombinant PTPalphaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of human PTPalpha expressed in Escherichia coli after 5 mins by microplate spectrophotometer analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of human PTPalpha expressed in Escherichia coli after 5 mins by microplate spectrophotometer analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMpH: 7.0Assay Description:Inhibition of PTPalpha expressed in Escherichia coli assessed as inhibition of p-nitrophenyl phosphate hydrolysis at pH 7 by spectrophotometryMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of phosphatase activity of human PTPalpha using pNPP as a substrate after 10 mins by spectrophotometer analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of phosphatase activity of human PTPalpha using pNPP as a substrate after 10 mins by spectrophotometer analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of phosphatase activity of human PTPalpha using pNPP as a substrate after 10 mins by spectrophotometer analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of human PTPalpha expressed in Escherichia coli after 5 mins by microplate spectrophotometer analysisMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.10E+4nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.20E+4nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.80E+4nMpH: 7.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 9.30E+4nMpH: 5.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 5More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of His-tagged PTPalpha (unknown origin) expressed in Escherichia coli BL21 cells using para-nitrophenyl phosphate as substrate incubated f...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:For selectivity studies, the PTPs, including LYP, mPTPA, SHP1-D1C, PTP1B, LMPTP, VHR, Laforin and PTPα-D1D2 were expressed and purified from E. ...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of PTPalpha (unknown origin)More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of PTPalpha (unknown origin)More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of His-tagged PTPalpha (unknown origin) expressed in Escherichia coli BL21 cells using para-nitrophenyl phosphate as substrate incubated f...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.08E+5nMpH: 5.0Assay Description:Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 5More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase alpha(Human)
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of His-tagged PTPalpha (unknown origin) expressed in Escherichia coli BL21 cells using para-nitrophenyl phosphate as substrate incubated f...More data for this Ligand-Target Pair